| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,220 |
12,442 |
$817K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
10,204 |
6,768 |
$725K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,749 |
8,358 |
$345K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
40,735 |
28,873 |
$237K |
| 99215 |
Prolong outpt/office vis |
1,452 |
1,115 |
$111K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,264 |
3,442 |
$99K |
| 77014 |
|
3,901 |
709 |
$96K |
| 80053 |
Comprehensive metabolic panel |
17,161 |
13,183 |
$84K |
| 77427 |
|
717 |
334 |
$76K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
660 |
538 |
$25K |
| 96367 |
|
870 |
586 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
14,238 |
12,506 |
$17K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,663 |
1,716 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
94 |
87 |
$8K |
| 82728 |
|
1,043 |
1,007 |
$8K |
| J0185 |
Injection, aprepitant, 1 mg |
21 |
12 |
$4K |
| 83550 |
|
840 |
811 |
$4K |
| 99195 |
|
61 |
54 |
$4K |
| 77263 |
|
43 |
41 |
$4K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
196 |
138 |
$4K |
| 83540 |
|
828 |
799 |
$3K |
| 77300 |
|
45 |
37 |
$3K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
411 |
355 |
$2K |
| J1453 |
Injection, fosaprepitant, 1 mg |
26 |
15 |
$2K |
| 36416 |
|
5,239 |
3,567 |
$2K |
| 77334 |
|
20 |
13 |
$1K |
| 99205 |
Prolong outpt/office vis |
19 |
14 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
26 |
24 |
$826.83 |
| 77290 |
|
14 |
14 |
$746.48 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
96 |
75 |
$592.41 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
33 |
15 |
$560.73 |
| 82607 |
|
41 |
38 |
$263.74 |
| 99441 |
|
19 |
13 |
$155.48 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
58 |
40 |
$107.41 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
115 |
75 |
$61.99 |
| J3490 |
Unclassified drugs |
18 |
12 |
$21.30 |
| G9678 |
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement |
13 |
13 |
$0.00 |